Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease

Hiroko H. Dodge, Jian Zhu, Danielle Harvey, Naomi Saito, Lisa C. Silbert, Jeffrey A. Kaye, Robert A. Koeppe, Roger L. Albin

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences